Although currently there is no direct evidence demonstrating the risk of insulin in initiating PDA in genetic mutation carriers and family history, the activation of insulin signal pathway and circulating hyperinsulinemia elevated the cancer risk in mutated gene carriers (Ding et al., 2012; Argirion et al., 2017). The gene discussed is INS; the disease is Hyperinsulinemia.